AdvisorShares Pure US Cannabis ETF
MSOS, an ETF, and TRLV, one of its holdings, fell about 8-9% after hours as a federal judge paused a cannabis rescheduling case. The delay impacts investors' expectations for near-term changes to marijuana's legal status, which could affect the industry.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning MSOS (AdvisorShares Pure US Cannabis ETF). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
The pause likely triggers sell pressure on the ETF as investors reassess the regulatory outlook.
AlphAI scores every news story that mentions MSOS with an AI model for sentiment and relevance, and aggregates insider trades from AdvisorShares Pure US Cannabis ETF's SEC EDGAR Form 4 filings. Figures refresh continuously.
MSOS, an ETF, and TRLV, one of its holdings, fell about 8-9% after hours as a federal judge paused a cannabis rescheduling case. The delay impacts investors' expectations for near-term changes to marijuana's legal status, which could affect the industry.
2 min read